364 related articles for article (PubMed ID: 20970440)
1. Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.
Kienhuis AS; Bessems JG; Pennings JL; Driessen M; Luijten M; van Delft JH; Peijnenburg AA; van der Ven LT
Toxicol Appl Pharmacol; 2011 Jan; 250(2):96-107. PubMed ID: 20970440
[TBL] [Abstract][Full Text] [Related]
2. Parallelogram approach using rat-human in vitro and rat in vivo toxicogenomics predicts acetaminophen-induced hepatotoxicity in humans.
Kienhuis AS; van de Poll MC; Wortelboer H; van Herwijnen M; Gottschalk R; Dejong CH; Boorsma A; Paules RS; Kleinjans JC; Stierum RH; van Delft JH
Toxicol Sci; 2009 Feb; 107(2):544-52. PubMed ID: 19008212
[TBL] [Abstract][Full Text] [Related]
3. Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment.
Wilson VS; Keshava N; Hester S; Segal D; Chiu W; Thompson CM; Euling SY
Toxicol Appl Pharmacol; 2013 Sep; 271(3):299-308. PubMed ID: 21295051
[TBL] [Abstract][Full Text] [Related]
4. Toxicogenomics-based prediction of acetaminophen-induced liver injury using human hepatic cell systems.
Rodrigues RM; Heymans A; De Boe V; Sachinidis A; Chaudhari U; Govaere O; Roskams T; Vanhaecke T; Rogiers V; De Kock J
Toxicol Lett; 2016 Jan; 240(1):50-9. PubMed ID: 26497421
[TBL] [Abstract][Full Text] [Related]
5. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
[TBL] [Abstract][Full Text] [Related]
6. Integrating toxicogenomics into human health risk assessment: lessons learned from the benzo[a]pyrene case study.
Chepelev NL; Moffat ID; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Malik AI; Halappanavar S; Williams A; Yauk CL
Crit Rev Toxicol; 2015 Jan; 45(1):44-52. PubMed ID: 25605027
[TBL] [Abstract][Full Text] [Related]
7. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
[TBL] [Abstract][Full Text] [Related]
8. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
Youns M; Hoheisel JD; Efferth T
Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
[TBL] [Abstract][Full Text] [Related]
9. Development of novel tools for the in vitro investigation of drug-induced liver injury.
Jiang J; Wolters JE; van Breda SG; Kleinjans JC; de Kok TM
Expert Opin Drug Metab Toxicol; 2015; 11(10):1523-37. PubMed ID: 26155718
[TBL] [Abstract][Full Text] [Related]
10. dbZach toxicogenomic information management system.
Burgoon LD; Zacharewski TR
Pharmacogenomics; 2007 Mar; 8(3):287-91. PubMed ID: 17324117
[TBL] [Abstract][Full Text] [Related]
11. The use of genomics in model in vitro systems.
Casciano DA
Adv Exp Med Biol; 2012; 745():210-20. PubMed ID: 22437820
[TBL] [Abstract][Full Text] [Related]
12. Contribution of new technologies to characterization and prediction of adverse effects.
Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
[TBL] [Abstract][Full Text] [Related]
13. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
[TBL] [Abstract][Full Text] [Related]
14. Toxicogenomics: regulatory perspective on current position.
Battershill JM
Hum Exp Toxicol; 2005 Jan; 24(1):35-40. PubMed ID: 15727054
[TBL] [Abstract][Full Text] [Related]
15. The human hepatocyte TXG-MAPr: gene co-expression network modules to support mechanism-based risk assessment.
Callegaro G; Kunnen SJ; Trairatphisan P; Grosdidier S; Niemeijer M; den Hollander W; Guney E; Piñero Gonzalez J; Furlong L; Webster YW; Saez-Rodriguez J; Sutherland JJ; Mollon J; Stevens JL; van de Water B
Arch Toxicol; 2021 Dec; 95(12):3745-3775. PubMed ID: 34626214
[TBL] [Abstract][Full Text] [Related]
16. Application of toxicogenomics to toxicology: basic concepts in the analysis of microarray data.
Irwin RD; Boorman GA; Cunningham ML; Heinloth AN; Malarkey DE; Paules RS
Toxicol Pathol; 2004; 32 Suppl 1():72-83. PubMed ID: 15209406
[TBL] [Abstract][Full Text] [Related]
17. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.
Blomme EA; Yang Y; Waring JF
Toxicol Lett; 2009 Apr; 186(1):22-31. PubMed ID: 18996174
[TBL] [Abstract][Full Text] [Related]
18. Toxicogenomic profiling of chemically exposed humans in risk assessment.
McHale CM; Zhang L; Hubbard AE; Smith MT
Mutat Res; 2010 Dec; 705(3):172-83. PubMed ID: 20382258
[TBL] [Abstract][Full Text] [Related]
19. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
[TBL] [Abstract][Full Text] [Related]
20. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
Stierum R; Heijne W; Kienhuis A; van Ommen B; Groten J
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):179-88. PubMed ID: 16139318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
